Trial Details

COMPLETED
Basic Information
Clinical ID c1605
Identifier NCT02306798
Trial Title TP0502-B-Pharmaco-Scintigraphic-Study
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: TP05
Participant Information
Sponsor Tillotts Pharma AG
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-09-13
Primary Completion Date 2025-11-13
Completion Date 2025-12-13